Schonfeld Strategic Advisors LLC - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 109 filers reported holding VIKING THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$596,673
-19.9%
53,900
+17.3%
0.01%
-16.7%
Q2 2023$744,897
-86.5%
45,953
-86.1%
0.01%
-88.7%
Q1 2023$5,500,410
+333.0%
330,355
+144.4%
0.05%
+381.8%
Q4 2022$1,270,354
+496.4%
135,144
+72.8%
0.01%
+450.0%
Q3 2022$213,000
-16.1%
78,220
-10.8%
0.00%0.0%
Q2 2022$254,000
-93.6%
87,720
-81.5%
0.00%
-98.6%
Q2 2019$3,946,000
-39.3%
475,400
-27.3%
0.14%
-38.1%
Q1 2019$6,504,000654,3000.23%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 450,900$2,624,0000.85%
Sio Capital Management, LLC 709,780$4,131,0000.82%
KNOTT DAVID M 218,102$1,269,0000.74%
ArrowMark Colorado Holdings LLC 7,988,635$46,494,0000.44%
Park West Asset Management LLC 1,457,507$8,483,0000.33%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 1,657$10,0000.18%
Virtus ETF Advisers LLC 42,507$247,0000.13%
Cornerstone Capital, Inc. 125,465$730,0000.10%
L & S Advisors Inc 114,988$669,0000.09%
EXANE DERIVATIVES 44,877$261,170,0000.08%
View complete list of VIKING THERAPEUTICS INC shareholders